Visnadine

DB13355InvestigationalSmall molecule

Visnadine: Overview.

Mechanism: Pharmacologically active on Voltage gated L-type calcium channel
Curator reviewed
Formula / weight: C₂₁H₂₄O₇ · 388.416 g/mol (avg)

Resolves to

Compound

Clinical / RWD

Structure

InChIKeyGVBNSPFBYXGREE-CXWAGAITSA-NSMILES[H][C@@](C)(CC)C(=O)O[C@]1([H])[C@]([H])(OC(C)=O)C2=C(OC1(C)C)C=CC1=C2OC(=O)C=C1

What you can answer from here — as of July 07, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

1ATC codeIncluding every combination product, plus 4 drug categories

1+ReferenceStructured and connected to the statements they support

Which companies are running trials of Visnadine, in which indications and phases, and which of those programs are still active?

Create a free account or log in to explore the full data card.